Author:
Rotta Katarina,VanDerwall Rena,Ehrhardt Kristal,Poling Alan
Publisher
Springer International Publishing
Reference76 articles.
1. Aman, M. G., Smith, T., Arnold, L. E., Corbett-Dick, P., Tumuluru, R., Hollway, J. A., Hyman, S. L., Mendoza-Burchamm, M., Pan, X., Mruzek, D. W., Lecavalier, L., Levato, L., Silverman, L. B., & Handen, B. (2014). A review of atomoxetine effects in young people with developmental disabilities. Research in Developmental Disabilities, 35, 1412–1424. https://doi.org/10.1016/j.ridd.2014.03.006
2. American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). Author.
3. Axmon, A., Kristensson, J., Ahlström, G., & Midlöv, P. (2017). Use of antipsychotics, benzodiazepine derivatives, and dementia medication among older people with intellectual disability and/or autism spectrum disorder and dementia. Research in Developmental Disabilities, 62, 50–57. https://doi.org/10.1016/j.ridd.2017.01.001
4. Ballester, P., Martínez, M. J., Inda, M. D., Javaloyes, A., Richdale, A. L., Muriel, J., Belda, C., Toral, N., Morales, D., Fernández, E., & Peiró, A. M. (2019). Evaluation of agomelatine for the treatment of sleep problems in adults with autism spectrum disorder and co-morbid intellectual disability. Journal of psychopharmacology (Oxford, England), 33, 1395–1406. https://doi.org/10.1177/0269881119864968
5. Baribeau, D. A., & Anagnostou, E. (2013). Social communication is an emerging target for pharmacotherapy in autism spectrum disorder – A review of the literature for potential agents. Journal of the Canadian Academy of Child and Adolescent Psychiatry, 23, 20–30.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献